AKAM Stock Analysis: Akamai Technologies | NASDAQ
Software - Infrastructure | NASDAQ, USA | Market Cap: 11.187m USD | 12M Return: 13.8% | US00971T1016 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 457M
EPS Trend: -56.6%
Qual. Beats: 0
Rev. Trend: 99.4%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Akamai Technologies (NASDAQ: AKAM) is a U.S.-headquartered internet services and infrastructure company that provides security, content delivery, and cloud computing solutions to customers globally. Incorporated in Massachusetts and listed on NASDAQ since 1999, Akamai operates as a large-cap stock within the Information Technology sector.
The company organizes its offerings into three main pillars. Its security solutions protect web, API, and mobile application traffic through products that defend against bot abuse, account takeover, credential stuffing, content scraping, and API vulnerabilities. Its delivery solutions focus on web and mobile performance acceleration, global traffic management, load balancing, real-user monitoring, and media delivery services such as video streaming and broadcast operations. Its cloud computing services provide compute, storage, networking, and the Akamai App Platform, which simplifies the deployment and scaling of Kubernetes clusters.
Akamai also holds a strategic alliance with Deloitte Canada aimed at helping organizations build platform-based resilience against AI-accelerated cyberthreats, reflecting the growing overlap between cloud infrastructure providers and the managed cybersecurity services market.
- Security segment growth drives margin expansion
- Cloud computing revenue scales on enterprise workload migration
- Hyperscaler competition pressures legacy CDN delivery margins
| Net Income: 387.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -5.27 > 1.0 |
| NWC/Revenue: 58.04% < 20% (prev 29.44%; Δ 28.59% < -1%) |
| CFO/TA 0.09 > 3% & CFO 1.44b > Net Income 387.9m |
| Net Debt (7.71b) to EBITDA (1.24b): 6.22 < 3 |
| Current Ratio: 2.13 > 1.5 & < 3 |
| Outstanding Shares: last quarter (151.2m) vs 12m ago 2.81% < -2% |
| Gross Margin: 55.37% > 18% (prev 59.13%; Δ -3.76% > 0.5%) |
| Asset Turnover: 33.28% > 50% (prev 38.15%; Δ -4.87% > 0%) |
| Interest Coverage Ratio: 10.34 > 6 (EBIT TTM 495.8m / Interest Expense TTM 48.0m) |
| A: 0.16 (Total Current Assets 4.81b - Total Current Liabilities 2.26b) / Total Assets 15.5b |
| B: 0.22 (Retained Earnings 3.42b / Total Assets 15.5b) |
| C: 0.04 (EBIT TTM 495.8m / Avg Total Assets 13.2b) |
| D: 0.50 (Book Value of Equity 5.15b / Total Liabilities 10.4b) |
| Altman-Z'' = 2.57 = A |
| DSRI: 1.18 (Receivables 958.5m/765.9m, Revenue 4.39b/4.13b) |
| GMI: 1.07 (GM 59.13% / 55.37%) |
| AQI: 0.78 (AQ_t 0.38 / AQ_t-1 0.49) |
| SGI: 1.06 (Revenue 4.39b / 4.13b) |
| TATA: -0.07 (NI 387.9m - CFO 1.44b) / TA 15.5b) |
| Beneish M = -2.91 (Cap -4..+1) = A |
As of November 09, 2026, the stock is trading at USD 83.09 with a total of 10,390,092 shares traded. Over the past week, the price has changed by -10.39%, over one month by -23.50%, over three months by -29.91% and over the past year by +13.82%.
Current recommended Stop Loss: 76.80 (which is 7.6% or 1.2 ATR below the current price).
Akamai Technologies has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy AKAM.
- StrongBuy: 11
- Buy: 4
- Hold: 8
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 154.2 | 85.6% |
P/E Trailing = 30.2879
P/E Forward = 12.5945
P/S = 2.5879
P/B = 2.6007
P/EG = 0.9992
Revenue TTM = 4.39b USD
EBIT TTM = 495.8m USD
EBITDA TTM = 1.24b USD
Long Term Debt = 4.11b USD (from longTermDebt, last fiscal year)
Short Term Debt = 1.54b USD (from shortTermDebt, last quarter)
Debt = 11.2b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.78b
Net Debt = 7.71b USD (calculated: Debt 11.2b - CCE 3.52b)
Enterprise Value = 18.9b USD (11.2b + Debt 11.2b - CCE 3.52b)
Interest Coverage Ratio = 10.34 (Ebit TTM 495.8m / Interest Expense TTM 48.0m)
EV/FCF = 89.56x (Enterprise Value 18.9b / FCF TTM 210.9m)
FCF Yield = 1.12% (FCF TTM 210.9m / Enterprise Value 18.9b)
FCF Margin = 4.80% (FCF TTM 210.9m / Revenue TTM 4.39b)
Net Margin = 8.84% (Net Income TTM 387.9m / Revenue TTM 4.39b)
Gross Margin = 55.37% ((Revenue TTM 4.39b - Cost of Revenue TTM 1.96b) / Revenue TTM)
Gross Margin QoQ = 55.02% (prev 55.81%)
Tobins Q-Ratio = 1.22 (Enterprise Value 18.9b / Total Assets 15.5b)
Interest Expense / Debt = 0.43% (Interest Expense 48.0m / Debt 11.2b)
Taxrate = 16.47% (76.5m / 464.4m)
NOPAT = 414.2m (EBIT 495.8m * (1 - 16.47%))
Current Ratio = 2.13 (Total Current Assets 4.81b / Total Current Liabilities 2.26b)
Debt / Equity = 2.18 (Debt 11.2b / totalStockholderEquity, last quarter 5.15b)
Debt / EBITDA = 6.22 (Net Debt 7.71b / EBITDA 1.24b)
Debt / FCF = 36.53 (Net Debt 7.71b / FCF TTM 210.9m)
Total Stockholder Equity = 4.95b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.94% (Net Income 387.9m / Total Assets 15.5b)
RoE = 7.84% (Net Income TTM 387.9m / Total Stockholder Equity 4.95b)
RoCE = 5.48% (EBIT 495.8m / Capital Employed (Equity 4.95b + L.T.Debt 4.11b))
RoIC = 2.84% (NOPAT 414.2m / Invested Capital 14.6b)
WACC = 5.33% (E(11.2b)/V(22.4b) * Re(10.31%) + D(11.2b)/V(22.4b) * Rd(0.43%) * (1-Tc(0.16)))
Discount Rate = 10.31% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -30.80 | Cagr: -0.70%
[DCF] Terminal Value 73.10% ; FCFF base≈413.9m ; Y1≈363.0m ; Y5≈293.3m
[DCF] Fair Price = N/A (negative equity: EV 4.71b - Net Debt 7.71b = -3.00b; debt exceeds intrinsic value)
EPS Correlation: -56.60 | EPS CAGR: -4.55% | SUE: 0.14 | # QB: 0
Revenue Correlation: 99.42 | Revenue CAGR: 5.04% | SUE: 0.55 | # QB: 0
EPS current Quarter (2027-03-31): EPS=1.58 | Chg30d=-0.59% | Revisions=-36% | Analysts=13
EPS current Year (2026-12-31): EPS=6.64 | Chg30d=+0.08% | Revisions=-56% | GrowthEPS=-6.7% | GrowthRev=+6.7%
EPS next Year (2027-12-31): EPS=6.83 | Chg30d=-0.25% | Revisions=-45% | GrowthEPS=+2.8% | GrowthRev=+16.1%
[Analyst] Revisions Ratio: -52% (up=9, down=32)